» Articles » PMID: 25314249

Association of Markers of Hemostasis with Death in HIV-infected Women

Abstract

: In HIV negatives, markers of hemostasis, including D-dimer, factor VIII, plasminogen activator inhibitor-1 antigen (PAI-1), and total protein S are associated with all-cause and cardiovascular disease mortality. In HIV positives, studies of D-dimer and factor VIII with death were limited to short follow-up; associations of PAI-1 and total protein S with death have not been examined. In 674 HIV-infected women from the Women's Interagency HIV Study, markers from the first visit after enrollment were exposures of interest in multivariate analyses of death (AIDS and non-AIDS) in separate models at 5 and 16 years. There were 87 AIDS and 44 non-AIDS deaths at 5 years, and 159 AIDS and 113 non-AIDS deaths at 16 years. An inverse association of total protein S quartiles with non-AIDS deaths was observed at 5 (P trend = 0.002) and 16 years (P trend = 0.02); there was no association with AIDS deaths. The third quartile of PAI-1 was associated with AIDS deaths at 5 [hazard ratio (HR) = 4.0; 95% confidence interval (CI): 1.9 to 8.4] and 16 years (HR = 3.4; 95% CI: 1.9 to 5.9); and with non-AIDS deaths at 5 years (HR = 4.8; 95% CI: 1.6 to 13.9). D-dimer and factor VIII were not associated with AIDS or non-AIDS death at 5 or 16 years. Lower total Protein S was a consistent marker of non-AIDS death. We found no association between D-dimer with AIDS or non-AIDS death, in contrast to previous studies showing increased short-term (<5 years) mortality, which may represent sex differences or population heterogeneity. Given longer survival on highly active antiretroviral therapy, further studies of these markers are needed to determine their prognostic value.

Citing Articles

Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.

Kiefer E, Hoover D, Shi Q, Dusingize J, Sinayobye J, Anastos K HIV Med. 2018; 19(10):734-744.

PMID: 30160347 PMC: 6911728. DOI: 10.1111/hiv.12665.


Basic Coagulation Parameters among Human Immunodeficiency Virus-Infected Adults in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study.

Seyoum M, Enawgaw B, Getaneh Z, Engidaye G, Asrie F, Melku M Biomed Res Int. 2018; 2018:5320827.

PMID: 29888267 PMC: 5977028. DOI: 10.1155/2018/5320827.


Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy.

Montoya J, Iudicello J, Oppenheim H, Fazeli P, Potter M, Ma Q AIDS. 2017; 31(6):787-795.

PMID: 28099190 PMC: 5466004. DOI: 10.1097/QAD.0000000000001404.

References
1.
Keenan C, White R . The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med. 2007; 13(5):377-83. DOI: 10.1097/MCP.0b013e3281eb8ef0. View

2.
Justice A, Freiberg M, Tracy R, Kuller L, Tate J, Goetz M . Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?. Clin Infect Dis. 2012; 54(7):984-94. PMC: 3297653. DOI: 10.1093/cid/cir989. View

3.
Bacon M, von Wyl V, Alden C, Sharp G, Robison E, Hessol N . The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005; 12(9):1013-9. PMC: 1235804. DOI: 10.1128/CDLI.12.9.1013-1019.2005. View

4.
Trotti R, Rondanelli M, Anesi A . Thrombophilic condition in HIV-infected patients. Haematologica. 1998; 82(6):733-4. View

5.
Ten Kate M, van der Meer J . Protein S deficiency: a clinical perspective. Haemophilia. 2008; 14(6):1222-8. DOI: 10.1111/j.1365-2516.2008.01775.x. View